Related Experiment Video
Updated: May 25, 2026

Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
Formulation and evaluation of fast dissolving tablets of cinnarizine using superdisintegrant blends and subliming
Biswajit Basu1, Abhishek Bagadiya, Sagar Makwana
1Department of Pharmaceutics, Atmiya Institute of Pharmacy, Yogidham Gurukul, Rajkot, Gujarat, India.
Abstract:
The aim of this investigation was to develop fast dissolving tablet of cinnarizine. A combination of super disintegrants, i.e., sodium starch glycolate (SSG) and crosscarmellose sodium (CCS) were used along with camphor as a subliming material. An optimized concentration of camphor was added to aid the porosity of the tablet. A 3(2) full factorial design was applied to investigate the combined effect of two formulation variables: Amount of SSG and CCS. Infrared (IR) spectroscopy was performed to identify the physicochemical interaction between drug and polymer. IR spectroscopy showed that there is no interaction of drug with polymer. In the present study, direct compression was used to prepare the tablets. The powder mixtures were compressed into tablet using flat face multi punch tablet machine. Camphor was sublimed from the tablet by exposing the tablet to vacuum drier at 60°C for 12 hours. All the formulations were evaluated for their characteristics such as average weight, hardness, wetting time, friability, content uniformity, dispersion time (DT), and dissolution rate. An optimized tablet formulation (F 9) was found to have good hardness of 3.30 ± 0.10 kg/cm(2), wetting time of 42.33 ± 4.04 seconds, DT of 34.67 ± 1.53 seconds, and cumulative drug release of not less than 99% in 16 minutes.
Related Concept Videos
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Factors Influencing Drug Absorption: Pharmaceutical Parameters
In Vitro Drug Dissolution: Alternative Methods
Factors Affecting Dissolution: Particle Size and Effective Surface Area
In Vitro Drug Dissolution: Compendial Testing Models I
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
